COR Cencora

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: Pharmaceutical distribution competing with manufacturers, chain drugstores, specialty distributors, packaging, and healthcare technology firms
• • Emphasized regulatory compliance due to new U.S. and EU laws (DSCSA, Falsified Medicines Directive, EU Critical Medicines Act, EU HTA Regulation effective Jan 2025)

Risk Factors

• • Board oversight of cybersecurity delegated to Audit Committee and Compliance and Risk Committee with quarterly meetings and ongoing updates
• • CDIO with 25+ years experience and CISO with 20+ years oversee cybersecurity risk management and incident response

Management Discussion & Analysis

• • Revenue $321.3B, up 9.3% YoY; U.S. Healthcare Solutions revenue $291.0B, up 9.7% ($25.6B increase); International Solutions $30.4B, up 6.1% ($1.7B increase)
• • Operating margin total 0.82% approx. (operating income $2.63B / revenue $321.3B); U.S. Healthcare margin 1.23%, up 12 bps YoY; International margin decreased 9.1% YoY

Risk Factors

• • No material changes in risk factors compared to 10-K for fiscal year ended September 30, 2025
• • Carried-forward regulatory risk: potential impact of evolving healthcare laws on pricing and reimbursement policies

Management Discussion & Analysis

• • Revenue $85.9B, up 5.5% YoY (+$4.4B); U.S. Healthcare Solutions +5.0% ($3.7B), International Healthcare Solutions +9.6% ($0.7B)
• • Gross profit $3.07B, up 20.1% YoY; U.S. Healthcare Solutions margin 2.47% (+46 bps), International Healthcare Solutions +3.3% gross profit increase

What are the latest COR SEC filings in 2026?

Cencora (COR) has filed a 10-K annual report on November 25, 2025, a 10-Q quarterly report on February 4, 2026, an 8-K current report on March 23, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did COR file its most recent 10-K annual report?

Cencora (COR) filed its most recent 10-K annual report on November 25, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view COR 10-Q quarterly reports?

Cencora (COR)'s most recent 10-Q quarterly report was filed on February 4, 2026. SignalX displays every COR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has COR filed recently?

Cencora (COR)'s most recent 8-K was filed on March 23, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find COR insider trading activity (Form 4)?

SignalX aggregates every COR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does COR file with the SEC?

Cencora (COR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new COR filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Cencora (COR).

What is COR's SEC CIK number?

Cencora (COR)'s SEC CIK (Central Index Key) number is 1140859. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1140859 to look up all COR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find COR return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Cencora (COR) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.